Signal vs. Record
Signal vs. Record
Where the podcast-and-influencer conversation about peptides meets the primary-source record — one real claim at a time, checked calmly against what the documents actually establish.
For BPC-157 there is a large gap between the animal research and human clinical evidence, and a key safety concern is that BPC-157 upregulates VEGF to promot…
AccurateCompounded semaglutide is the same as Ozempic or Wegovy — identical drug, just cheaper — so there's no meaningful difference in getting it from a compounder.
MisleadingBecause the FDA removed BPC-157 from the Category 2 "do not compound" list in April 2026, it is now legal for compounding pharmacies to prepare it and for co…
MisleadingBPC-157 is widely used for wound and injury healing and there are many animal studies showing efficacy, but essentially no clinical trials and few human stud…
AccurateAbout 14 of the restricted peptides (including BPC-157) are expected to move from Category 2 back to Category 1 "within a couple of weeks," restoring the pat…
PrematureIV NAD+ drips are far more effective than oral precursors — 100% bioavailable and worth the high price — for energy, recovery, and anti-aging.
MisleadingMelanotan II — the "Barbie drug" — is a safe, easy way to get a deep tan, and it even helps protect the skin against sun damage and skin cancer.
MisleadingBoosting NAD+ — with NMN or NR supplements, or NAD+ IV drips — reverses aging and is a proven longevity breakthrough.
Unsupported